ProCE Banner Activity

Pharmacists Discuss Key HCP Questions on BTK Inhibitors

Clinical Thought

In this short commentary, expert pharmacists respond to frequently asked questions from HCPs on best practices in the use of BTK inhibitors for CLL and MCL.

Released: December 23, 2022

Expiration: December 22, 2023

Share

Supporters

Supported by an educational grant from

Pharmacyclics LLC, an AbbVie Company

Partners

National Association of Specialty Pharmacy

ProCE Banner